Intas Pharmaceuticals files IPO papers with SEBI
Intas Pharmaceuticals that engaged in the development, manufacture and marketing of pharmaceutical formulations has filed IPO papers with SEBI.
June 20, 2013 / 13:14 IST
Gujarat-based Intas Pharmaceuticals has filed draft red herring prospectus (DRHP) with market regulator SEBI to list its public issue on exchanges.
Intas Pharmaceuticals is engaged in the development, manufacture and marketing of pharmaceutical formulations.Healthcare firm intends to use issue proceeds for marketing authorization expenses; setting up of research and development facility; and general corporate purposes.Equity shares are proposed to be listed on the NSE and the BSE.Kotak Mahindra Capital Company Limited and Morgan Stanley India Company Private Limited are the book running lead managers, however Link Intime India Private Limited is the registrar to the issue. Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
